menu

A Review of Risk in Cervical Cancer: An Analysis of the ASCCP Guidelines & NCI Risk Matrix

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A Review of Risk in Cervical Cancer: An Analysis of the ASCCP Guidelines & NCI Risk Matrix

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

The latest ASCCP Risk-Based Management Consensus Guidelines use current and past results, and other factors, to create individualized assessments of a patient’s immediate risk of precancer. How will using these guidelines impact the way you screen patients for cervical cancer?

  • Sponsored by

  • Overview

    From the approval of an HPV test with extended genotyping to the role of the NCI Risk Matrix, what do we need to know about the ASCCP Risk-Based Management Consensus Guidelines, and how will these updates impact the treatment pathways we recommend to our patients being screening for cervical cancer? Dr. Jeffery Andrews shares guideline recommendations and updates. 

Schedule25 Sep 2022
Webpack App